| Title | Author(s) | Year | View Count |
 | Pharmacokinetics of LB80331 and LB80317 following oral administration of LB80380, a new antiviral agent for chronic hepatitis B (CHB), in healthy adult subjects, CHB patients, and mice | Yuen, MF; Lee, SH; Kang, HM; Chung, RK; Kim, J; Ngai, V; Lai, CL | 2009 | 451 |
| A randomized placebo-controlled, dose-finding study of oral LB80380 in HBeAg-positive patients with chronic hepatitis B | Yuen, MF; Kim, J; Kim, CR; Ngai, V; Yuen, JCH; Min, C; Kang, HM; Shin, BS; Yoo, SD; Lai, CL | 2006 | 202 |
|
